Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease

被引:12
|
作者
Alongi, Filippo [1 ,5 ]
Arcangeli, Stefano [2 ]
Triggiani, Luca [3 ]
Mazzola, Rosario [1 ]
di Monale e Bastia, Michela Buglione [3 ]
Fersino, Sergio [1 ]
Baiguini, Anna [3 ]
Jereczek-Fossa, Barbara Alicja [4 ]
Magrini, Stefano Maria [3 ]
机构
[1] Sacro Cuore Don Calabria Canc Care Ctr, Radiat Oncol, Negrar Verona, Italy
[2] San Camillo & Forlanini Hosp, Radiat Oncol, Rome, Italy
[3] Spedali Civili Brescia, Radiat Oncol, Brescia, Italy
[4] Univ Milan, European Inst Oncol, Radiat Oncol, Milan, Italy
[5] Univ Brescia, Brescia, Italy
关键词
Stereotactic radiotherapy; SABR; Renal cell carcinoma; Oligometastases; INITIAL CLINICAL-EXPERIENCE; DOSE-PER-FRACTION; BODY RADIOTHERAPY; SPINAL METASTASES; FOLLOW-UP; RADIOSURGERY; CANCER; IMMUNOTHERAPY; NEPHRECTOMY; KIDNEY;
D O I
10.1016/j.critrevonc.2017.07.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Renal Cell Carcinoma (RCC) has historically been considered a radioresistant cancer, and radiotherapy was usually delivered with a palliative goal. Stereotactic ablative radiotherapy (SABR) allows the delivery of high doses on small treatment volumes in a safe and effective way, thus opening the doors to new applicationsof radiotherapy both in the treatment of the primary and oligometastasic disease. Aim of the current review is to explore the state of art of SABR in the therapeutic approach to RCC. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:48 / 56
页数:9
相关论文
共 50 条
  • [1] Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies
    Zaorsky, Nicholas G.
    Lehrer, Eric J.
    Kothari, Gargi
    Louie, Alexander, V
    Siva, Shankar
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (05): : 515 - 523
  • [2] Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma
    Campbell, Scott P.
    Song, Daniel Y.
    Pierorazio, PhillipM.
    Allaf, Mohamad E.
    Gorin, Michael A.
    JOURNAL OF ONCOLOGY, 2015, 2015
  • [3] Stereotactic ablative radiotherapy for primary renal cell carcinoma
    Yang, Daniel X.
    Kwon, Young Suk
    Timmerman, Robert
    Hannan, Raquibul
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 44
  • [4] Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC
    All, Sean
    Garant, Aurelie
    Hannan, Raquibul
    SEMINARS IN RADIATION ONCOLOGY, 2021, 31 (03) : 227 - 234
  • [5] Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function
    Senger, C.
    Conti, A.
    Kluge, A.
    Pasemann, D.
    Kufeld, M.
    Acker, G.
    Lukas, M.
    Gruen, A.
    Kalinauskaite, G.
    Budach, V.
    Waiser, J.
    Stromberger, C.
    BMC UROLOGY, 2019, 19 (01)
  • [6] Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases
    Wang, Chiachien Jake
    Christie, Alana
    Lin, Mu-Han
    Jung, Matthew
    Weix, Derek
    Huelsmann, Lorel
    Kuhn, Kristin
    Meyer, Jeffrey
    Desai, Neil
    Kim, D. W. Nathan
    Pedrosa, Ivan
    Margulis, Vitaly
    Cadeddu, Jeffrey
    Sagalowsky, Arthur
    Gahan, Jeffrey
    Laine, Aaron
    Xie, Xian-Jin
    Choy, Hak
    Brugarolas, James
    Timmerman, Robert
    Hannan, Raquibul
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 91 - 100
  • [7] The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma
    Ciro Franzese
    Beatrice Marini
    Davide Baldaccini
    Marco Badalamenti
    Pierina Navarria
    Luisa Bellu
    Davide Franceschini
    Tiziana Comito
    Elena Clerici
    Maria Ausilia Teriaca
    Maria Massaro
    Luciana Di Cristina
    Lorenzo Lo Faro
    Stefano Tomatis
    Marta Scorsetti
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 4411 - 4417
  • [8] The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma
    Franzese, Ciro
    Marini, Beatrice
    Baldaccini, Davide
    Badalamenti, Marco
    Navarria, Pierina
    Bellu, Luisa
    Franceschini, Davide
    Comito, Tiziana
    Clerici, Elena
    Teriaca, Maria Ausilia
    Massaro, Maria
    Di Cristina, Luciana
    Lo Faro, Lorenzo
    Tomatis, Stefano
    Scorsetti, Marta
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (08) : 4411 - 4417
  • [9] The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive disease
    Marandino, Laura
    Ciccarese, Chiara
    Francolini, Giulio
    Amparore, Daniele
    Campi, Riccardo
    MINERVA UROLOGY AND NEPHROLOGY, 2023, 75 (02): : 260 - 264
  • [10] Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma
    Franzese, Ciro
    Franceschini, Davide
    Di Brina, Lucia
    D'Agostino, Giuseppe Roberto
    Navarria, Pierina
    Comito, Tiziana
    Mancosu, Pietro
    Tomatis, Stefano
    Scorsetti, Marta
    JOURNAL OF UROLOGY, 2019, 201 (01) : 70 - 75